Deerfield Private Design Fund Iv, L.p. - Net Worth and Insider Trading
Deerfield Private Design Fund Iv, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Deerfield Private Design Fund Iv, L.p. owns 20 companies in total, including Annexon Inc (ANNX) , Nkarta Inc (NKTX) , and Larimar Therapeutics Inc (LRMR) among others .
Insider Ownership Summary of Deerfield Private Design Fund Iv, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ANNX | Annexon Inc | 2020-07-23 | 10 percent owner & other: Possible Member of 10% Group |
| NKTX | Nkarta Inc | 2020-07-09 | 10 percent owner & other: Possible Member of 10% Group |
| LRMR | Larimar Therapeutics Inc | 2020-05-28 | director & 10 percent owner & other: Director by Deputization |
 | | 2020-03-13 | director & 10 percent owner & other: Director by Deputization |
| | 2020-02-12 | 10 percent owner & other: Possible Member of 10% Group |
| | 2020-02-05 | 10 percent owner & other: Possible Member of 10% Group |
| | 2019-11-08 | director & 10 percent owner & other: * Director by Deputization |
| | 2019-10-24 | 10 percent owner & other: Possible Member of 10% Group |
| | 2019-10-02 | 10 percent owner & other: Possible Member of 10% Group |
| | 2019-07-17 | 10 percent owner & other: Possible Member of 10% Group |
| | 2018-09-26 | 10 percent owner & other: Possible Member of 10% Group |
| | 2017-08-02 | director & other: *Director by Deputization |
| | 2021-03-25 | 10 percent owner & other: Possible Member of 10% Group |
| | 2018-02-15 | director & 10 percent owner & other: Director by Deputization |
| | 2020-03-10 | director & 10 percent owner & other: *Director by Deputization |
| | 2021-05-26 | 10 percent owner & other: *Possible Member of 10% Group |
| | 2021-07-28 | director & 10 percent owner & other: Director by Deputization |
| | 2022-11-08 | director & 10 percent owner & other: * Director by deputization |
| | 2022-11-08 | director & 10 percent owner & other: * Director by deputization |
| | 2019-10-02 | 10 percent owner & other: Possible Member of 10% Group |
Deerfield Private Design Fund Iv, L.p. Trading Performance
Deerfield Private Design Fund Iv, L.p. Ownership Network
Ownership Network List of Deerfield Private Design Fund Iv, L.p.
Ownership Network Relation of Deerfield Private Design Fund Iv, L.p.
Deerfield Private Design Fund Iv, L.p. Owned Company Details
What does Annexon Inc do?
Who are the key executives at Annexon Inc?
Deerfield Private Design Fund Iv, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Annexon Inc. Other key executives at Annexon Inc include EVP & Chief Innovation Officer Ted Yednock , EVP & Chief Business Officer Michael Overdorf , and EVP & Chief Financial Officer Jennifer Lew .
Annexon Inc (ANNX) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iv, L.p. made no insider transaction in Annexon Inc (ANNX). Other recent insider transactions involving Annexon Inc (ANNX) include a net sale of 74,985 shares made by Ted Yednock , a net purchase of 22,400 shares made by William H. Carson , and a net sale of 6,563 shares made by Jennifer Lew .
In summary, during the past 3 months, insiders sold 26,408 shares of Annexon Inc (ANNX) in total and bought 6,400 shares, with a net sale of 20,008 shares. During the past 18 months, 92,392 shares of Annexon Inc (ANNX) were sold and 672,400 shares were bought by its insiders, resulting in a net purchase of 580,008 shares.
Annexon Inc (ANNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Annexon Inc Insider Transactions
- Download to Excel(.xls)
What does Nkarta Inc do?
Who are the key executives at Nkarta Inc?
Deerfield Private Design Fund Iv, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Nkarta Inc. Other key executives at Nkarta Inc include Chief Legal Officer Alicia J. Hager , Chief Medical Officer David Shook , and Sr. VP & Technical Operations Ralph Brandenberger .
Nkarta Inc (NKTX) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iv, L.p. made no insider transaction in Nkarta Inc (NKTX). Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 9,598 shares made by James Trager , a net sale of 9,378 shares made by Alicia J. Hager , and a net sale of 5,778 shares made by David Shook .
In summary, during the past 3 months, insiders sold 0 shares of Nkarta Inc (NKTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 41,413 shares of Nkarta Inc (NKTX) were sold and 5,000,000 shares were bought by its insiders, resulting in a net purchase of 4,958,587 shares.
Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nkarta Inc Insider Transactions
- Download to Excel(.xls)
What does Larimar Therapeutics Inc do?
Who are the key executives at Larimar Therapeutics Inc?
Deerfield Private Design Fund Iv, L.p. is the director & 10 percent owner & other: Director by Deputization of Larimar Therapeutics Inc. Other key executives at Larimar Therapeutics Inc include 10 percent owner & other: Possible Member of 10% Group James E Flynn , Chief Development Officer Gopi Shankar , and Chief Medical Officer Russell Clayton .
Larimar Therapeutics Inc (LRMR) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iv, L.p. made no insider transaction in Larimar Therapeutics Inc (LRMR). Other recent insider transactions involving Larimar Therapeutics Inc (LRMR) include a net purchase of 4,290,617 shares made by James E Flynn , a net purchase of 57,208 shares made by Thomas Edward Hamilton , and a net purchase of 5,000 shares made by Carole Ben-maimon .
In summary, during the past 3 months, insiders sold 0 shares of Larimar Therapeutics Inc (LRMR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Larimar Therapeutics Inc (LRMR) were sold and 4,367,575 shares were bought by its insiders, resulting in a net purchase of 4,367,575 shares.
Larimar Therapeutics Inc (LRMR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Larimar Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does DFP Healthcare Acquisitions Corp do?
Who are the key executives at DFP Healthcare Acquisitions Corp?
Deerfield Private Design Fund Iv, L.p. is the director & 10 percent owner & other: Director by Deputization of DFP Healthcare Acquisitions Corp. Other key executives at DFP Healthcare Acquisitions Corp include director & 10 percent owner & other: Director by Deputization Deerfield Management Company, L.p. (series C) , director & 10 percent owner & other: Director by Deputization Deerfield Mgmt L.p. , and director & 10 percent owner & other: Director by Deputization Deerfield Partners, L.p. .
DFP Healthcare Acquisitions Corp (DFPHU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of DFP Healthcare Acquisitions Corp (DFPHU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DFP Healthcare Acquisitions Corp (DFPHU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
DFP Healthcare Acquisitions Corp (DFPHU)'s detailed insider trading history can be found in Insider Trading Tracker table.
DFP Healthcare Acquisitions Corp Insider Transactions
- Download to Excel(.xls)
What does Revolution Medicines Inc do?
Who are the key executives at Revolution Medicines Inc?
Deerfield Private Design Fund Iv, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Revolution Medicines Inc. Other key executives at Revolution Medicines Inc include General Counsel Jeff Cislini , director & See Remarks Mark A Goldsmith , and See Remarks Stephen Michael Kelsey .
Revolution Medicines Inc (RVMD) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iv, L.p. made no insider transaction in Revolution Medicines Inc (RVMD). Other recent insider transactions involving Revolution Medicines Inc (RVMD) include a net sale of 34,044 shares made by Jeff Cislini , a net sale of 186,391 shares made by Stephen Michael Kelsey , and a net sale of 265,672 shares made by Mark A Goldsmith .
In summary, during the past 3 months, insiders sold 249,942 shares of Revolution Medicines Inc (RVMD) in total and bought 0 shares, with a net sale of 249,942 shares. During the past 18 months, 718,995 shares of Revolution Medicines Inc (RVMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 718,995 shares.
Revolution Medicines Inc (RVMD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Revolution Medicines Inc Insider Transactions
- Download to Excel(.xls)
What does Schrodinger Inc do?
Who are the key executives at Schrodinger Inc?
Deerfield Private Design Fund Iv, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Schrodinger Inc. Other key executives at Schrodinger Inc include Chief Medical Officer Margaret Dugan , EVP & CFO Geoffrey Craig Porges , and See Remarks Robert Lorne Abel .
Schrodinger Inc (SDGR) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iv, L.p. made no insider transaction in Schrodinger Inc (SDGR). Other recent insider transactions involving Schrodinger Inc (SDGR) include a net sale of 35,758 shares made by Yvonne Tran , a net sale of 20,901 shares made by Kenneth Patrick Lorton , and a net sale of 14,850 shares made by Nancy Thornberry .
In summary, during the past 3 months, insiders sold 1,531 shares of Schrodinger Inc (SDGR) in total and bought 0 shares, with a net sale of 1,531 shares. During the past 18 months, 78,347 shares of Schrodinger Inc (SDGR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 78,347 shares.
Schrodinger Inc (SDGR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Schrodinger Inc Insider Transactions
- Download to Excel(.xls)
What does AdaptHealth Corp do?
Who are the key executives at AdaptHealth Corp?
Deerfield Private Design Fund Iv, L.p. is the director & 10 percent owner & other: * Director by Deputization of AdaptHealth Corp. Other key executives at AdaptHealth Corp include Chief Accounting Officer Frank Mullen , 10 percent owner Cashin Richard M Jr , and 10 percent owner One Equity Partners Vii, L.p. .
AdaptHealth Corp (DFBHU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AdaptHealth Corp (DFBHU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AdaptHealth Corp (DFBHU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AdaptHealth Corp (DFBHU)'s detailed insider trading history can be found in Insider Trading Tracker table.
AdaptHealth Corp Insider Transactions
- Download to Excel(.xls)
What does Cabaletta Bio Inc do?
Who are the key executives at Cabaletta Bio Inc?
Deerfield Private Design Fund Iv, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Cabaletta Bio Inc. Other key executives at Cabaletta Bio Inc include EVP & Science & Technology Gwendolyn Binder , director & President & CEO Steven Nichtberger , and Chief Financial Officer Anup Marda .
Cabaletta Bio Inc (CABA) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iv, L.p. made no insider transaction in Cabaletta Bio Inc (CABA). Other recent insider transactions involving Cabaletta Bio Inc (CABA) include a net sale of 110,000 shares made by Gwendolyn Binder ,
In summary, during the past 3 months, insiders sold 0 shares of Cabaletta Bio Inc (CABA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 110,000 shares of Cabaletta Bio Inc (CABA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 110,000 shares.
Cabaletta Bio Inc (CABA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cabaletta Bio Inc Insider Transactions
- Download to Excel(.xls)
What does Frequency Therapeutics Inc do?
Who are the key executives at Frequency Therapeutics Inc?
Deerfield Private Design Fund Iv, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Frequency Therapeutics Inc. Other key executives at Frequency Therapeutics Inc include director & President and CEO David L. Lucchino , VP Finance & Operations Richard J. Mitrano , and Chief Scientific Officer Christopher R. Loose .
Frequency Therapeutics Inc (FREQ) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iv, L.p. made no insider transaction in Frequency Therapeutics Inc (FREQ). Other recent insider transactions involving Frequency Therapeutics Inc (FREQ) include a net sale of 97,675 shares made by David L. Lucchino , a net sale of 8,202 shares made by Richard J. Mitrano , and a net sale of 26,723 shares made by Christopher R. Loose .
In summary, during the past 3 months, insiders sold 0 shares of Frequency Therapeutics Inc (FREQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 132,600 shares of Frequency Therapeutics Inc (FREQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,600 shares.
Frequency Therapeutics Inc (FREQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Frequency Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Mirum Pharmaceuticals Inc do?
Who are the key executives at Mirum Pharmaceuticals Inc?
Deerfield Private Design Fund Iv, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Mirum Pharmaceuticals Inc. Other key executives at Mirum Pharmaceuticals Inc include director & 10 percent owner Patrick J Heron , SVP & Global Controller Jolanda Howe , and Chief Scientific Officer Pamela Vig .
Mirum Pharmaceuticals Inc (MIRM) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iv, L.p. made no insider transaction in Mirum Pharmaceuticals Inc (MIRM). Other recent insider transactions involving Mirum Pharmaceuticals Inc (MIRM) include a net purchase of 162,308 shares made by Patrick J Heron , a net sale of 8,512 shares made by Jolanda Howe , and a net sale of 34,606 shares made by Pamela Vig .
In summary, during the past 3 months, insiders sold 0 shares of Mirum Pharmaceuticals Inc (MIRM) in total and bought 345 shares, with a net purchase of 345 shares. During the past 18 months, 105,850 shares of Mirum Pharmaceuticals Inc (MIRM) were sold and 176,308 shares were bought by its insiders, resulting in a net purchase of 70,458 shares.
Mirum Pharmaceuticals Inc (MIRM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mirum Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Arvinas Inc do?
Who are the key executives at Arvinas Inc?
Deerfield Private Design Fund Iv, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Arvinas Inc. Other key executives at Arvinas Inc include Chief Accounting Officer David K Loomis , Chief Medical Officer Ronald Peck , and Chief Financial Officer Sean A Cassidy .
Arvinas Inc (ARVN) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iv, L.p. made no insider transaction in Arvinas Inc (ARVN). Other recent insider transactions involving Arvinas Inc (ARVN) include a net sale of 3,023 shares made by Ronald Peck , a net sale of 5,196 shares made by John G Houston , and a net sale of 1,702 shares made by Sean A Cassidy .
In summary, during the past 3 months, insiders sold 460 shares of Arvinas Inc (ARVN) in total and bought 0 shares, with a net sale of 460 shares. During the past 18 months, 12,082 shares of Arvinas Inc (ARVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 12,082 shares.
Arvinas Inc (ARVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arvinas Inc Insider Transactions
- Download to Excel(.xls)
What does Protara Therapeutics Inc do?
Who are the key executives at Protara Therapeutics Inc?
Deerfield Private Design Fund Iv, L.p. is the director & other: *Director by Deputization of Protara Therapeutics Inc. Other key executives at Protara Therapeutics Inc include 10 percent owner Opaleye Management Inc. , Chief Financial Officer Patrick Fabbio , and director & CEO and President Jesse Shefferman .
Protara Therapeutics Inc (TARA) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iv, L.p. made no insider transaction in Protara Therapeutics Inc (TARA). Other recent insider transactions involving Protara Therapeutics Inc (TARA) include a net sale of 703,460 shares made by Opaleye Management Inc. ,
In summary, during the past 3 months, insiders sold 220,893 shares of Protara Therapeutics Inc (TARA) in total and bought 0 shares, with a net sale of 220,893 shares. During the past 18 months, 703,460 shares of Protara Therapeutics Inc (TARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 703,460 shares.
Protara Therapeutics Inc (TARA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protara Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Edgewise Therapeutics Inc do?
Who are the key executives at Edgewise Therapeutics Inc?
Deerfield Private Design Fund Iv, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Edgewise Therapeutics Inc. Other key executives at Edgewise Therapeutics Inc include General Counsel John R Moore , CMO Joanne M. Donovan , and Chief Financial Officer R Michael Carruthers .
Edgewise Therapeutics Inc (EWTX) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iv, L.p. made no insider transaction in Edgewise Therapeutics Inc (EWTX). Other recent insider transactions involving Edgewise Therapeutics Inc (EWTX) include a net sale of 111,210 shares made by John R Moore , a net sale of 249,161 shares made by Alan J Russell , and a net sale of 217,249 shares made by R Michael Carruthers .
In summary, during the past 3 months, insiders sold 320,244 shares of Edgewise Therapeutics Inc (EWTX) in total and bought 0 shares, with a net sale of 320,244 shares. During the past 18 months, 645,402 shares of Edgewise Therapeutics Inc (EWTX) were sold and 919,947 shares were bought by its insiders, resulting in a net purchase of 274,545 shares.
Edgewise Therapeutics Inc (EWTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Edgewise Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does AdaptHealth Corp do?
Who are the key executives at AdaptHealth Corp?
Deerfield Private Design Fund Iv, L.p. is the director & 10 percent owner & other: Director by Deputization of AdaptHealth Corp. Other key executives at AdaptHealth Corp include Chief Revenue Officer Shaw Rietkerk , director & 10 percent owner & other: Director by Deputization James E Flynn , and Chief Technology Officer Albert A. Prast .
AdaptHealth Corp (AHCO) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iv, L.p. made no insider transaction in AdaptHealth Corp (AHCO). Other recent insider transactions involving AdaptHealth Corp (AHCO) include a net sale of 335,443 shares made by Albert A. Prast , a net sale of 10,764 shares made by Williams David Solomon Iii , and a net sale of 350,000 shares made by James E Flynn .
In summary, during the past 3 months, insiders sold 33,509 shares of AdaptHealth Corp (AHCO) in total and bought 0 shares, with a net sale of 33,509 shares. During the past 18 months, 1,046,834 shares of AdaptHealth Corp (AHCO) were sold and 720 shares were bought by its insiders, resulting in a net sale of 1,046,114 shares.
AdaptHealth Corp (AHCO)'s detailed insider trading history can be found in Insider Trading Tracker table.
AdaptHealth Corp Insider Transactions
- Download to Excel(.xls)
What does The Oncology Institute Inc do?
Who are the key executives at The Oncology Institute Inc?
Deerfield Private Design Fund Iv, L.p. is the director & 10 percent owner & other: *Director by Deputization of The Oncology Institute Inc. Other key executives at The Oncology Institute Inc include 10 percent owner Havencrest Healthcare Partners, L.p. , Chief Financial Officer & other: Principal Financial Officer Mihir Shah , and director & Chief Executive Officer Brad Hively .
The Oncology Institute Inc (TOI) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iv, L.p. made no insider transaction in The Oncology Institute Inc (TOI). Other recent insider transactions involving The Oncology Institute Inc (TOI) include a net sale of 80,000 shares made by Havencrest Healthcare Partners, L.p. , a net sale of 72,000 shares made by Brad Hively , and a net purchase of 100,000 shares made by Mihir Shah .
In summary, during the past 3 months, insiders sold 0 shares of The Oncology Institute Inc (TOI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 152,000 shares of The Oncology Institute Inc (TOI) were sold and 100,000 shares were bought by its insiders, resulting in a net sale of 52,000 shares.
The Oncology Institute Inc (TOI)'s detailed insider trading history can be found in Insider Trading Tracker table.
The Oncology Institute Inc Insider Transactions
- Download to Excel(.xls)
What does Singular Genomics Systems Inc do?
Who are the key executives at Singular Genomics Systems Inc?
Deerfield Private Design Fund Iv, L.p. is the 10 percent owner & other: *Possible Member of 10% Group of Singular Genomics Systems Inc. Other key executives at Singular Genomics Systems Inc include director & 10 percent owner & Chief Executive Officer Andrew Spaventa , Chief Scientific Officer Eli N. Glezer , and Chief Operating Officer Jyotsna Ghai .
Singular Genomics Systems Inc (OMIC) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iv, L.p. made no insider transaction in Singular Genomics Systems Inc (OMIC). Other recent insider transactions involving Singular Genomics Systems Inc (OMIC) include a net purchase of 370,000 shares made by Eli N. Glezer , a net purchase of 118,293 shares made by Andrew Spaventa , and a net sale of 631,648 shares made by Kim P. Kamdar .
In summary, during the past 3 months, insiders sold 175 shares of Singular Genomics Systems Inc (OMIC) in total and bought 122,416 shares, with a net purchase of 122,241 shares. During the past 18 months, 21,230 shares of Singular Genomics Systems Inc (OMIC) were sold and 138,698 shares were bought by its insiders, resulting in a net purchase of 117,468 shares.
Singular Genomics Systems Inc (OMIC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Singular Genomics Systems Inc Insider Transactions
- Download to Excel(.xls)
What does Nuvalent Inc do?
Who are the key executives at Nuvalent Inc?
Deerfield Private Design Fund Iv, L.p. is the director & 10 percent owner & other: Director by Deputization of Nuvalent Inc. Other key executives at Nuvalent Inc include See Remarks Darlene Noci , Chief Financial Officer Alexandra Balcom , and director & 10 percent owner & other: Director by Deputization James E Flynn .
Nuvalent Inc (NUVL) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iv, L.p. made no insider transaction in Nuvalent Inc (NUVL). Other recent insider transactions involving Nuvalent Inc (NUVL) include a net sale of 536,000 shares made by Matthew Shair , a net sale of 143,000 shares made by Darlene Noci , and a net sale of 124,546 shares made by Deborah Ann Miller .
In summary, during the past 3 months, insiders sold 2,146,629 shares of Nuvalent Inc (NUVL) in total and bought 0 shares, with a net sale of 2,146,629 shares. During the past 18 months, 3,924,068 shares of Nuvalent Inc (NUVL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,924,068 shares.
Nuvalent Inc (NUVL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nuvalent Inc Insider Transactions
- Download to Excel(.xls)
What does Silverback Therapeutics Inc do?
Who are the key executives at Silverback Therapeutics Inc?
Deerfield Private Design Fund Iv, L.p. is the director & 10 percent owner & other: * Director by deputization of Silverback Therapeutics Inc. Other key executives at Silverback Therapeutics Inc include Chief Operating Officer Brian Dorsey , Chief Legal Officer Alexander A Fitzpatrick , and director & 10 percent owner & other: * Director by deputization Deerfield Management Company, L.p. (series C) .
Silverback Therapeutics Inc (SBTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Silverback Therapeutics Inc (SBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Silverback Therapeutics Inc (SBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Silverback Therapeutics Inc (SBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Silverback Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does ARS Pharmaceuticals Inc do?
Who are the key executives at ARS Pharmaceuticals Inc?
Deerfield Private Design Fund Iv, L.p. is the director & 10 percent owner & other: * Director by deputization of ARS Pharmaceuticals Inc. Other key executives at ARS Pharmaceuticals Inc include Chief Financial Officer Kathleen D. Scott , 10 percent owner & Chief Medical Officer Sarina Tanimoto , and director & 10 percent owner & President and CEO Richard E Lowenthal .
ARS Pharmaceuticals Inc (SPRY) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iv, L.p. made no insider transaction in ARS Pharmaceuticals Inc (SPRY). Other recent insider transactions involving ARS Pharmaceuticals Inc (SPRY) include a net sale of 1,603,260 shares made by Sarina Tanimoto , a net sale of 1,603,260 shares made by Richard E Lowenthal , and a net sale of 400,000 shares made by Laura Shawver .
In summary, during the past 3 months, insiders sold 2,999,754 shares of ARS Pharmaceuticals Inc (SPRY) in total and bought 0 shares, with a net sale of 2,999,754 shares. During the past 18 months, 5,636,274 shares of ARS Pharmaceuticals Inc (SPRY) were sold and 8,937,557 shares were bought by its insiders, resulting in a net purchase of 3,301,283 shares.
ARS Pharmaceuticals Inc (SPRY)'s detailed insider trading history can be found in Insider Trading Tracker table.
ARS Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Korro Bio Inc do?
Who are the key executives at Korro Bio Inc?
Deerfield Private Design Fund Iv, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Korro Bio Inc. Other key executives at Korro Bio Inc include Chief Financial Officer Vineet Agarwal , 10 percent owner Scott D Sandell , and 10 percent owner New Enterprise Associates 17, L.p. .
Korro Bio Inc (KRRO) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iv, L.p. made no insider transaction in Korro Bio Inc (KRRO). Other recent insider transactions involving Korro Bio Inc (KRRO) include a net sale of 11,016 shares made by Vineet Agarwal , a net sale of 2,124 shares made by David L. Lucchino , and a net purchase of 17,857 shares made by Atlas Venture Opportunity Fund Ii, L.p. .
In summary, during the past 3 months, insiders sold 11,016 shares of Korro Bio Inc (KRRO) in total and bought 0 shares, with a net sale of 11,016 shares. During the past 18 months, 13,140 shares of Korro Bio Inc (KRRO) were sold and 178,570 shares were bought by its insiders, resulting in a net purchase of 165,430 shares.
Korro Bio Inc (KRRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Korro Bio Inc Insider Transactions
- Download to Excel(.xls)
Deerfield Private Design Fund Iv, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Deerfield Private Design Fund Iv, L.p.. You might contact Deerfield Private Design Fund Iv, L.p. via mailing address: 780 Third Avenue 37th Floor, New York Ny 10017.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
